<DOC>
	<DOCNO>NCT00069251</DOCNO>
	<brief_summary>The purpose study assess efficacy safety bupropion reduce methamphetamine use subject methamphetamine dependence</brief_summary>
	<brief_title>Bupropion Treatment Methamphetamine Dependence - 1</brief_title>
	<detailed_description>A double-blind , placebo-controlled , parallel-group design study 100 subject randomly assign placebo bupropion 12 week follow-up assessment 4 week follow treatment . Adaptive randomization use balance treatment group base gender .</detailed_description>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Subject must methamphetamine dependence determine DSMIV diagnosis Subject must willing comply study procedure . Ability verbalize understanding consent form , provide write consent , verbalize willingness complete study procedure Be able comply protocol requirement Please contact site information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>amphetamine dependence</keyword>
</DOC>